Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David G Gaiero Insider Profile
4 Followers
David G Gaiero, Interim CFO at Wave Life Sciences, holds 102.39K shares in Cyteir Therapeutics (Ticker: CYT), holds 6.39K shares in Wave Life Sciences (Ticker: WVE).
David G Gaiero has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Interim CFO
Roles that David G Gaiero holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by David G Gaiero
David G Gaiero's Trading History
Wave Life Sciences
Feb 05, 2020
Interim CFO
Uninformative Sell
4.56K
$40.27K
Cyteir Therapeutics
Feb 07, 2023
―
Uninformative Buy
7.45K
$308.20K
List of latest transactions for each holding click on a transaction to see David G Gaiero's performance on stock
You May Also Like
David G Gaiero insider profile FAQ
What is the percentage of profitable transactions made by David G Gaiero?
The percentage of profitable transactions made by David G Gaiero is ―.
What is the average return per transaction made by David G Gaiero?
The average return per transaction made by David G Gaiero is ―.
What stocks does David G Gaiero hold?
David G Gaiero holds: WVE, CYT stocks.
What was David G Gaiero’s latest transaction?
David G Gaiero latest transaction was an Uninformative Buy of $7.45K.
What was David G Gaiero's most profitable transaction?
David G Gaiero’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is David G Gaiero's role in Wave Life Sciences?
David G Gaiero's role in Wave Life Sciences is Interim CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.